KG&L Capital Management »

Actuate Therapeutics shares owned by KG&L Capital Management

Quarter-by-quarter ownership of Actuate Therapeutics shares owned by KG&L Capital Management from 13F filings

Historical chart of KG&L Capital Management investment in Actuate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Actuate Therapeutics held by KG&L Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Actuate Therapeutics by KG&L Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $89k 12k 7.45

More positions owned by KG&L Capital Management

Procter & Gamble Company (PG)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arthur J. Gallagher & Co. (AJG)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Boeing Company (BA)

View all positions for KG&L Capital Management

Top funds holding Actuate Therapeutics

AWM Investment Company
Long Corridor Asset Management
Royal Bank of Canada
Geode Capital Management
Northwestern University
KG&L Capital Management
Citigroup
Wells Fargo & Company
Bank of America Corporation

View all funds holding Actuate Therapeutics